News Muncher - searching for institute

On September 1, 2022, the Government of India launched the new indigenous cervical cancer vaccine, Cervavac, in partnership with Serum Institute of India Private Limited. The introduction of this vaccine is a welcome step in the battle against cervical cancer in India where every eight minutes, one woman dies of this preventable disease. As cervical cancer is linked to sexual …

It will soon become easier for women to participate in the national cervical cancer monitoring program. Starting this week, every woman who turns 30 will receive a self-sampling kit with an invitation, the Dutch public health institute, RIVM, announced. Women aged between 35 and 60 who have not responded to the first invitation will also automatically receive a self-sampling kit …

Researchers have dropped a bomb by connecting a surge in throat cancer cases in UK and other western countries to oral sex. According to Hisham Mehanna, a professor at the University of Birmingham’s Institute of Cancer and Genomic Sciences, oropharyngeal cancer is now more common than cervical cancer in both the US and the UK. Prof Hisham said that numerous …

Centre is likely to include HPV vaccine in the national immunisation programme for girls aged nine to 14 years in June, sources close to the government informed adding that a global tender for the same is likely to be floated in April. Apart from domestic manufacturer Serum Institute of India, global vaccine manufacturer Merck is also likely to participate in …

Serum Institute of India Chief Executive Officer Adar Poonawalla said on Wednesday that the availability of the cervical cancer vaccine will be little in number in 2023. Speaking of the rollout of the cervical cancer vaccines, Adar Poonawalla said the vaccines would be rolled out through government programmes this year. The first made-in-India Human Papillomavirus "CERVAVAC" vaccine, for the prevention …

Serum Institute launches country’s first HPV vaccine against cervical cancer: Adar Poonawalla

On the occasion of National Girl Child Day, the Serum Institute of India on Tuesday launched the first indigenously developed human papillomavirus vaccine -- “CERVAVAC,” against the cervical cancer in women. “On the occasion of India’s National Girl Child Day and Cervical Cancer Awareness Month, @SerumInstIndia is pleased to launch the first made-in-India HPV vaccine by the hands of our …

Serum Institute

Pune-based pharmaceutical firm Serum Institute of India will soon launch CERVAVAC, India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer. On June 15, 2022, the DCGI’s Subject Expert Committee recommended the qHPV vaccine developed by the SII for cervical cancer patients belonging to the age group of nine to 26 years. HPV vaccines are important because they could …

The Department of Biotechnology in partnership with the Serum Institute of India is set to launch India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer on Thursday, the Centre said in a statement on Wednesday. According to the World Health Organisation, India accounts for about a fifth of the global burden for cervical cancer, witnessing about 1.23 lakh …

The Drugs Controller General of India on Tuesday granted market authorisation to Serum Institute of India to manufacture indigenously-developed India’s first Quadrivalent Human Papillomavirus vaccine against cervical cancer, official sources said. Prakash Kumar Singh, director at Serum Institute, had applied to the DCGI seeking market authorisation of qHPV after the phase 2/3 clinical trial was completed with support of the …

An expert panel of India's central drug authority on Wednesday recommended granting market authorisation to the Serum Institute of India to manufacture indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine against cervical cancer, official sources said. Prakash Kumar Singh, director at SII had applied to the Drugs Controller General of India on June 8 for market authorisation of qHPV after completing …

Cervical cancer: Serum Institute’s vaccine to hit the market soon

On June 15, the Subject expert committee will discuss the Serum Institute of India's first indigenously designed quadrivalent human papillomavirus vaccine against cervical cancer. The qHPV vaccine will be India's first indigenously-curated cervical cancer vaccine. "Like many other indigenous life-saving vaccines, we are committed to make our country 'ATMANIRBHAR' for India's first indigenous life-saving qHPV vaccine also. This will fulfill …